Maria Carrillo, MD
Critical Care Medicine · Orlando, FLNPI 1588673289
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,158 of the $1,470 with a category attached, or 78.8%. 11 manufacturers reported payments, led by Abiomed at 41.3% of the total. Reporting peaked in 2019 at $697 and has fallen 89.9% since, to $70 in 2025.
Across 20 payments — averaging $73.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$608
- Bayer$125
- Paratek Pharmaceuticals, Inc.$122
- Boehringer Ingelheim$122
- Tetraphase Pharmaceuticals, Inc.$119
- AstraZeneca$104
- plus $270 from 5 others
Across 5 payments — averaging $28,525 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$143K
What the payments were for
- Travel & lodging$31221%
- Food & beverage$1,15879%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 5 | $608 |
| Bayer | 1 | $125 |
| Paratek Pharmaceuticals, Inc. | 1 | $122 |
| Boehringer Ingelheim | 1 | $122 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $119 |
| AstraZeneca(2 entities) | 2 | $104 |
| Vapotherm Inc | 1 | $97 |
| Abbott | 4 | $92 |
| Cook Medical LLC | 2 | $34 |
| Merck | 1 | $24 |
| Boston Scientific | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,470 in reported general payments places this provider in the 75th percentile of 618 critical care medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Orlando
- Louis GuzziOrlando$635K
- Omid ZadOrlando$325K
- Charles HunleyOrlando$116K
- Martin ZamoraOrlando$44K
- Hammad BhattiOrlando$41K
- Dmitriy ZubkusOrlando$22K
- Amay ParikhOrlando$8K
- Sundeep GulianiOrlando$6K
- Fortune AlabiKissimmee$587K
- Debabrata BandyopadhyayTampa$398K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.